Mumbai,
Groupe Athena, Inc. (Pink sheets GATA.PK) is very excited to post the results for their fiscal year ending June 30, 2013. Annual revenue for the period was $56,457,443 which is an increase of more than 26% over the previous fiscal year and represents another new benchmark for the company. EBITDA for the year was also strong at $8,956,726 and net after tax income for the period was $5,440,694 or $.12 per share.
Current assets have risen to $10,287,188 as of June 30 andconsist of primarily cash and short term investments. The company does expectto use a portion of their retained earnings to begin the outfitting of theirrecently purchased new testing facility, and to pursue other anticipated growthinvestments to be announced.
Company Chairman, D. Purohit stated, "This is a very exciting time for Groupe Athena, Inc. as we transition from a start-up company to an established regional pharmaceutical force. As we develop new global and regional relationships, and as dynamics within our industry evolve, we are seeing many exciting opportunities unfold that we hope to capitalize on in the near term".
As previously stated, the company plans to apply for listing on the NASDAQ Bulletin Board quotation system and hopes to have all relevant SEC filings submitted and subsequent SEC approval by the fiscal year end.
To review the complete quarterly report please go to www.otcmarkets.com/stock/GATA/quote and click on "Financials"
The Indian pharmaceutical industry is increasingly focusing on exports to the
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in
The company has a research and marketing facility in
For more information contact:
Paul Cornell
Corporate Shareholder Relations, Inc.
Cornelllpaul6@gmail.com
Certain statements set forth in this press release constitute "forward-looking statements.Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate","project", "intend", "forecast","anticipate", "plan", "planning","expect", "believe", "will likely","should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- activities of competitors and the presence of new or additional competition and conditions of equity markets.